Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Obermayr

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Personalized Medicine|November 27, 2021
Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung CancerEva Obermayr, Nina Koppensteiner, Nicole Heinzl, et al.
International Journal of Molecular Sciences|October 16, 2024
Association of the Single Nucleotide Polymorphisms rs11556218, rs4778889, rs4072111, and rs1131445 of the Interleukin-16 Gene with Ovarian CancerRafał Watrowski, Eva Schuster, Toon Van Gorp, et al.
Acta Oncologica (Stockholm, Sweden)|January 26, 2011
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patientsRobert Königsberg, Eva Obermayr, Giovanna Bises, et al.
Plos One|October 13, 2015
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian CancerStefanie Aust, Thomas Knogler, Dietmar Pils, et al.
Clinical Chemistry and Laboratory Medicine|November 17, 2022
Effect of short-term storage of blood samples on gene expression in lung cancer patientsEva Obermayr, Nina Koppensteiner, Nicole Heinzl, et al.
Oncotarget|February 9, 2018
Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cellsEva Obermayr, Elisabeth Maritschnegg, Christiane Agreiter, et al.
Gynecologic Oncology|March 14, 2018
Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortiumJohanna M Gostner, Eva Obermayr, Ioana E Braicu, et al.
Cancers|January 11, 2022
tRNA<sup>GlyGCC</sup>-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and ProgressionKonstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn, et al.
Gynecologic Oncology|September 29, 2012
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortiumEva Obermayr, Dan Cacsire Castillo-Tong, Dietmar Pils, et al.
Cancers|April 12, 2022
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation StudyRafał Watrowski, Eva Obermayr, Christine Wallisch, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Personalized Medicine|November 27, 2021
Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung CancerEva Obermayr, Nina Koppensteiner, Nicole Heinzl, et al.
International Journal of Molecular Sciences|October 16, 2024
Association of the Single Nucleotide Polymorphisms rs11556218, rs4778889, rs4072111, and rs1131445 of the Interleukin-16 Gene with Ovarian CancerRafał Watrowski, Eva Schuster, Toon Van Gorp, et al.
Acta Oncologica (Stockholm, Sweden)|January 26, 2011
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patientsRobert Königsberg, Eva Obermayr, Giovanna Bises, et al.
Plos One|October 13, 2015
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian CancerStefanie Aust, Thomas Knogler, Dietmar Pils, et al.
Clinical Chemistry and Laboratory Medicine|November 17, 2022
Effect of short-term storage of blood samples on gene expression in lung cancer patientsEva Obermayr, Nina Koppensteiner, Nicole Heinzl, et al.
Oncotarget|February 9, 2018
Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cellsEva Obermayr, Elisabeth Maritschnegg, Christiane Agreiter, et al.
Gynecologic Oncology|March 14, 2018
Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortiumJohanna M Gostner, Eva Obermayr, Ioana E Braicu, et al.
Cancers|January 11, 2022
tRNA<sup>GlyGCC</sup>-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and ProgressionKonstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn, et al.
Gynecologic Oncology|September 29, 2012
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortiumEva Obermayr, Dan Cacsire Castillo-Tong, Dietmar Pils, et al.
Cancers|April 12, 2022
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation StudyRafał Watrowski, Eva Obermayr, Christine Wallisch, et al.
Pageof 4